Acquirente per organizzazione di ricerca a contratto in fase iniziale in Europa

Azienda ideale

• Dimensioni: Aziende di medie dimensioni
• Entrate: 2-20 M EUR
• Posizione dell'azienda target: Europa
• CFIE PHB329

Overview of buyer for early-stage Contract Research Organisation in Europe

A globally recognized specialist Contract Research Organization (CRO) is seeking to expand through the acquisition of early-stage CROs in Europe. As the world leader in human challenge trials, this organization focuses on testing infectious and respiratory disease vaccines and therapeutics, providing end-to-end early clinical development services to a diverse, international client base of pharmaceutical and biotechnology companies.

Profile of buyer for early-stage Contract Research Organisation in Europe

With a rich legacy of over two decades in conducting human challenge studies, the company has built a reputation for scientific excellence and operational innovation. It operates from multiple state-of-the-art facilities designed to deliver high-quality, compliant, and efficient clinical trial experiences. The organization’s mission is to empower innovation in healthcare and transform the drug development process through cutting-edge science and a future-focused vision.

Activity and Products of buyer for early-stage Contract Research Organisation in Europe

This CRO specializes in human challenge trials across a portfolio of 11+ challenge models including Influenza, RSV, HRV, Asthma, Cough, COPD, COVID-19, hMPV, and Malaria. It offers full-spectrum services tailored to the needs of pharmaceutical and biotech sponsors, ensuring strategic and effective early-phase clinical development. Additionally, the company operates a highly specialized virology and immunology laboratory that supports both pre-clinical and clinical respiratory drug and vaccine development. Its labs deliver precise, submission-ready data supported by rigorous scientific and quality standards.

Highlights of buyer for early-stage Contract Research Organisation in Europe

• Global leader in human challenge trial research with over 25 years of experience
• Operates the largest dedicated human challenge trial facility in the world, equipped with advanced laboratories and high-capacity quarantine units
• Offers a broad range of challenge study models and laboratory services, supporting diverse clinical and pre-clinical development needs
• Maintains multiple strategically located screening and recruitment sites for optimized participant enrollment
• Backed by a team of highly skilled scientists and clinicians, underpinned by a mission to revolutionize healthcare through scientific ingenuity

Ulteriori informazioni sul Acquirente per organizzazione di ricerca a contratto in fase iniziale in Europa

Non esiti a contattarci per saperne di più su questa Acquirente per organizzazione di ricerca a contratto in fase iniziale in Europa. Per ulteriori aziende cro in vendita visitate la sezione aziende cro in vendita. Per gli altri acquirenti di cro, visitare la sezione cercasi aziende di cro. Se invece le interessano le aziende farmaceutiche in vendita, visiti il sito aziende farmaceutiche in vendita sezione. Per gli acquirenti di prodotti farmaceutici, visiti la sezione cercasi aziende farmaceutiche.